A study of treatment of cancer cachexia and for reducing side effects of cancer treatment with conditioned medium

A study of treatment of cancer cachexia and for reducing side effects of standard cancer treatment with human-derived mesenchymal stem cell conditioned medium

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1051220093

Enrollment

Registered

2022-09-14

Start date

2022-08-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer cachexia, Side effects of cancer treatment

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who want to reduce side effects associated with cancer cachexia and cancer treatment. 2. Patients who have been judged by the doctor to be optimally treated with conditioned medium. Target patients who meet the following criteria. 1. 18 years old and over 2. Have normal consent ability 3. Patients who can obtain their free will consent in writing 4. Patients whose doctor have recognized the need for treatment

Exclusion criteria

Exclusion criteria: Patient who meet any of the following conditions are excluded 1. Have a history of or suspected of dementia 2. Users of narcotics or stimulants 3. Pregnant, breastfeeding 4. Judged unsuitable by the doctor

Design outcomes

Primary

Measure	Time frame
Common tumor markers tested during previous treatment,high-sensitive CRP, adiponectin, total antioxidant capacity, GDF15, galectin-3, grip strength, body composition, Image diagnosis by CT	—

Secondary

Measure	Time frame
subjective symptoms, etc.	—

Contacts

Public ContactYoshiki Murata

Seihoku Clinic

mochizuki@shhc.jp+81-78-998-1101

Outcome results